Tongue hyperpigmentation during interferon-alpha and ribavirin therapy

被引：6
|
作者：
Aguayo-Leiva, Ingrid [1 ]
Perez, Bibiana [1 ]
Salguero, Irene [1 ]
Jaen, Pedro [1 ]
机构：
[1] Hosp Ramon & Cajal, Dept Dermatol, E-28034 Madrid, Spain
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2009年 / 19卷 / 03期
关键词：
CHRONIC HEPATITIS-C; VIRUS;
D O I：
10.1684/ejd.2009.0665
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：291 / 292
页数：3
相关论文
共 50 条
  • [41] Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C
    Ueno, T
    Inuzuka, S
    Sata, M
    Koh, H
    Tamaki, S
    Kin, M
    Sugawara, H
    Sakata, R
    Torimura, T
    Tanikawa, K
    HEPATO-GASTROENTEROLOGY, 1995, 42 (05) : 522 - 527
  • [42] Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-alpha for chronic hepatitis C
    Kiehne, K
    Kloehn, S
    Hinrichsen, H
    Gallwitz, B
    Monig, H
    ENDOCRINE, 1997, 6 (03) : 231 - 234
  • [43] Monitoring of liver metabolic function during interferon-alpha therapy and its relationship to treatment outcome in chronic hepatitis C patients
    Giannini, E
    Fasoli, A
    Romagnoli, P
    Botta, F
    Fumagalli, A
    Polegato, S
    Sola, S
    Ceppa, P
    Testa, R
    HEPATO-GASTROENTEROLOGY, 2002, 49 (45) : 778 - 782
  • [44] BIOLOGICAL AND CLINICAL-SIGNIFICANCE OF NEUTRALIZING AND BINDING-ANTIBODIES TO INTERFERON-ALPHA (IFN-ALPHA) DURING THERAPY FOR CHRONIC HEPATITIS-C
    GIANNELLI, G
    ANTONELLI, G
    FERA, G
    DELVECCHIO, S
    RIVA, E
    BROCCIA, C
    SCHIRALDI, O
    DIANZANI, F
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1994, 97 (01): : 4 - 9
  • [45] Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C
    Yasuji Arase
    Kenji Ikeda
    Fumitaka Suzuki
    Yoshiyuki Suzuki
    Satoshi Saitoh
    Masahiro Kobayashi
    Norio Akuta
    Takashi Someya
    Tetsuya Hosaka
    Hitomi Sezaki
    Mariko Kobayashi
    Hiromitsu Kumada
    Journal of Gastroenterology, 2004, 39 : 1090 - 1094
  • [46] Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C
    Arase, Y
    Ikeda, K
    Suzuki, F
    Suzuki, Y
    Saitoh, S
    Kobayashi, M
    Akuta, N
    Someya, T
    Hosaka, T
    Sezaki, H
    Kobayashi, M
    Kumada, H
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (11) : 1090 - 1094
  • [47] Therapy Induced Anemia in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon Alpha and Ribavirin
    Mehdi, Syed Ghazanfar
    Faizi, Karim Shah
    Khan, Rao Saad Ali
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2013, 7 (01): : 204 - 206
  • [48] INTERFERON-ALPHA RETREATMENT IN CHRONIC HEPATITIS-C
    GERKEN, G
    TEUBER, G
    GOERGEN, B
    HERMANN, K
    ZUMBUSCHENFELDE, KHM
    JOURNAL OF HEPATOLOGY, 1995, 22 : 118 - 121
  • [49] Effects of Combined Interferon Alpha and Ribavirin Therapy on Thyroid Functions in Patients with Chronic Hepatitis C
    Nadeem, Amina
    Aslam, Muhammad
    Khan, Dilshad Ahmad
    Hussain, Tassawar
    Khan, Saadat Ali
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2009, 19 (02): : 86 - 90
  • [50] Pharmacokinetic Studies of the Recombinant Bovine Interferon-alpha in Cattle
    Yu, Hai-Yang
    Zhao, Yu
    Li, Shu-Qi
    Fu, Xiu-Le
    Zhou, Wei
    Xia, Bing-Bing
    Chen, Jason
    Zhao, Jun
    Wang, Ming-Li
    KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI, 2019, 25 (01) : 17 - 23
12345